Archive · May 2026
Expert-Bot Subscriptions Are Coming for AEC Niches — Read the Failure Modes Before You Sign Up
Onix's expert-bot subscription model has direct implications for AEC professionals. Here's the system architecture, the failure modes, and what to do now.
Your iOS Kernel R/W Primitive Is Step Zero — Here Is What Comes Next
A 2026 methodology extracts struct offsets from stripped iOS kernelcaches using Binary Ninja — and what it means for AEC field-device security.
Microsoft's Windows Insider Overhaul: What the Channel Restructure Actually Controls — and What It Hides
Microsoft restructures Windows Insider channels. What the CFR change, ARM 26H1 track, and telemetry gap mean for BIM and AEC firms in 2025.
When Football Blocks Docker: Spain's IP Censorship Is an Infrastructure Risk
A LaLiga court order blocks Cloudflare IPs during matches, silently failing Docker Hub pulls and CI/CD pipelines. Here's the system fix for AEC teams.
AI Code Agents Are Eating Software Development — Here's What That Means for Your Grasshopper Scripts
Claude Code, Codex, and Copilot are reshaping software development. Here's what AI coding agents mean for Grasshopper, Dynamo, and AEC scripting in 2026.
The Fear Is Real. The Story Is Wrong. What Scary AI Narratives Cost AEC Practitioners
Harari's GPT-4 story was misleading. But OpenAI and Anthropic both withheld models the same week. Here's the system architects need to read correctly.
Abridge AI Records Your Doctor. The Consent Gap That Should Keep Swiss BIM Teams Awake.
Class action against Sutter Health over AI recordings without consent—what nDSG, GDPR, and EU AI Act mean for DACH practices.
What happens when 1,000 people actually drive a robot
RAI Institute's 2025 Boston pop-up study shows direct Spot robot experience shifts public comfort more than media. What AEC pros need to know.
The GPT-4 Captcha Story Was Never What Harari Said It Was
The GPT-4 TaskRabbit story wasn't autonomous deception — Alignment Research Center transcripts show researchers scripted every step. What AEC pros must know.
When 'Vaccine' Becomes a Liability: Moderna's mRNA Naming Problem
Moderna rebranded its cancer vaccine as 'individualized neoantigen therapy'. What this naming battle means for mRNA innovation, regulation, and AEC classification logic.